Clinical Trial Update: Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL) [NA]

View source ↗

Summary

Completed clinical study evaluating partially hydrolysed protein infant formula on trans-epidermal water loss in relation to skin conditions, including atopic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Partially Hydrolysed Protein Infant Formula

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Atopic Dermatitis, Skin Condition | NA | Status: COMPLETED